Filing Details

Accession Number:
0001209191-24-001957
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-01-19 18:02:25
Reporting Period:
2024-01-17
Accepted Time:
2024-01-19 18:02:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1348911 Kalvista Pharmaceuticals Inc. KALV Pharmaceutical Preparations (2834) 200915291
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1615979 Y Bong Koh C/O Venrock
7 Bryant Park, 23Rd Floor
New York NY 10018
No No Yes No
1698082 P Nimish Shah C/O Venrock
7 Bryant Park, 23Rd Floor
New York NY 10018
No No Yes No
1738048 Venrock Healthcare Capital Partners Iii, L.p. C/O Venrock
7 Bryant Park, 23Rd Floor
New York NY 10018
No No Yes No
1738053 Vhcp Management Iii, Llc C/O Venrock
7 Bryant Park, 23Rd Floor
New York NY 10018
No No Yes No
1750761 Vhcp Co-Investment Holdings Iii, Llc C/O Venrock
7 Bryant Park, 23Rd Floor
New York NY 10018
No No Yes No
1808512 Venrock Healthcare Capital Partners Eg, L.p. C/O Venrock
7 Bryant Park, 23Rd Floor
New York NY 10018
No No Yes No
1808518 Vhcp Management Eg, Llc C/O Venrock
3340 Hillview Avenue
Palo Alto CA 94304
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-01-17 78,925 $12.60 4,394,971 No 4 P Indirect By Funds
Common Stock Acquisiton 2024-01-18 39,680 $12.51 4,434,651 No 4 P Indirect By Funds
Common Stock Acquisiton 2024-01-19 25,000 $12.43 4,459,651 No 4 P Indirect By Funds
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Funds
No 4 P Indirect By Funds
No 4 P Indirect By Funds
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.53 to $12.75 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  2. Consists of (i) 970,401 shares held by Venrock Healthcare Capital Partners III, L.P. ("VHCP3"); (ii) 97,074 shares held by VHCP Co-Investment Holdings III, LLC ("VHCP Co-3"); and (iii) 3,327,496 shares held by Venrock Healthcare Capital Partners EG, L.P. ("VHCP EG").
  3. VHCP Management III, LLC ("VHCPM3") is the general partner of VHCP3 and the manager of VHCP Co-3 and may be deemed to beneficially own these shares. VHCP Management EG, LLC ("VHCPMEG") is the general partner of VHCPEG and may be deemed to beneficially own these shares. Bong Koh and Nimish Shah are the voting members of VHCPM3 and VHCPMEG and may be deemed to beneficially own these shares. Each of VHCPM3, VHCPMEG and Messrs. Koh and Shah expressly disclaims beneficial ownership over these shares except to the extent of its or his indirect pecuniary interest therein.
  4. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.40 to $12.75 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  5. Consists of (i) 980,833 shares held by VHCP3; (ii) 98,117 shares held by VHCP Co-3; and (iii) 3,355,701 shares held by VHCP EG.
  6. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.21 to $12.50 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  7. Consists of (i) 980,833 shares held by VHCP3; (ii) 98,117 shares held by VHCP Co-3; and (iii) 3,380,701 shares held by VHCP EG.